Fidelity Investments
ZYME icon

Fidelity Investments’s Zymeworks ZYME Stock Holding History

Fidelity Investments’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4M Buy
702,568
+35,415
+5% +$900K ﹤0.01% 1907
2026
Q1 		$16.7M Buy
667,153
+107,067
+19% +$2.53M ﹤0.01% 1853
2025
Q4 		$14.7M Buy
560,086
+556,572
+15,839% +$12.1M ﹤0.01% 1891
2025
Q3 		$60K Buy
3,514
+404
+13% +$5.78K ﹤0.01% 3890
2025
Q2 		$39K Sell
3,110
-9,720
-76% -$116K ﹤0.01% 4006
2025
Q1 		$153K Sell
12,830
-9,136
-42% -$125K ﹤0.01% 3356
2024
Q4 		$322K Buy
21,966
+18,630
+558% +$261K ﹤0.01% 3080
2024
Q3 		$41.9K Buy
3,336
+1,525
+84% +$16.6K ﹤0.01% 3855
2024
Q2 		$15.4K Sell
1,811
-23,933
-93% -$213K ﹤0.01% 4167
2024
Q1 		$271K Buy
25,744
+151
+0.6% +$1.68K ﹤0.01% 2925
2023
Q4 		$266K Buy
25,593
+881
+4% +$7.02K ﹤0.01% 2866
2023
Q3 		$157K Buy
24,712
+10
+0% +$74 ﹤0.01% 2962
2023
Q2 		$213K Buy
+24,702
New +$221K ﹤0.01% 2935
2022
Q2 		– Sell
-547,078
Closed -$3.58M – 5566
2022
Q1 		$3.58M Sell
547,078
-2,944,469
-84% -$26.2M ﹤0.01% 2449
2021
Q4 		$57.2M Buy
3,491,547
+12,618
+0.4% +$263K ﹤0.01% 1370
2021
Q3 		$101M Buy
3,478,929
+15,997
+0.5% +$532K 0.01% 1106
2021
Q2 		$120M Sell
3,462,932
-1,278,720
-27% -$40.6M 0.01% 1044
2021
Q1 		$150M Sell
4,741,652
-2,056,603
-30% -$83.6M 0.01% 911
2020
Q4 		$321M Buy
6,798,255
+3,376,211
+99% +$157M 0.03% 551
2020
Q3 		$159M Buy
3,422,044
+6,559
+0.2% +$225K 0.02% 718
2020
Q2 		$123M Buy
3,415,485
+911
+0% +$33.6K 0.01% 796
2020
Q1 		$121M Buy
3,414,574
+460,524
+16% +$18.8M 0.02% 687
2019
Q4 		$134M Buy
2,954,050
+11,455
+0.4% +$416K 0.01% 804
2019
Q3 		$73M Buy
2,942,595
+116,690
+4% +$2.92M 0.01% 1020
2019
Q2 		$62.2M Buy
2,825,905
+424,008
+18% +$7.78M 0.01% 1118
2019
Q1 		$38.9M Buy
2,401,897
+1,845,142
+331% +$28.6M ﹤0.01% 1320
2018
Q4 		$8.17M Buy
+556,755
New +$7.31M ﹤0.01% 1867

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Fidelity Investments's ZYME Position: Q2 2026 in Review

Fidelity Investments increased its Zymeworks (ZYME) stake by 5.3% in Q2 2026, buying an estimated $900K and bringing the position to 702,568 shares worth $18.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1907.

Fidelity Investments first reported a position in ZYME in Q4 2018 and has held it in 27 quarters since. The position peaked at $321M in Q4 2020. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Fidelity Investments held 702,568 shares of Zymeworks worth $18.4M as of Q2 2026.
  • Fidelity Investments bought 35,415 Zymeworks shares in Q2 2026, an estimated $900K.
  • Zymeworks made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1907 holding.
  • Fidelity Investments first reported a position in Zymeworks in Q4 2018 and has held it in 27 quarters since.
  • Fidelity Investments's Zymeworks position peaked at $321M in Q4 2020.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.